Polygenic Risk Score May Aid Prediction of AF After Stroke
Clinical risk models for predicting risk for atrial fibrillation following stroke may be improved with the addition of a polygenic risk score.
Related Articles
Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes
Each valve was associated with certain benefits, but one-year outcomes were largely similar.
Intra-annular TAVR valves from Edwards Lifesciences and Abbott deliver similar 1-year outcomes
Each valve was associated with certain benefits, but one-year outcomes were largely similar.
Zoster Vax & Heart Disease; Jewel WCD OK’d; Carotid Revascularization for Low-Risk?
Recent developments of interest in cardiovascular medicine
Small Amounts of Processed Foods Tied to Big Health Risks, New Research Suggests | VegNews
Eating small amounts of processed foods daily may increase the risk of hypertension, heart disease, cancer, digestive disorders, and early death, according to a new…
Study blames pollution, unhealthy diets for regional heart disease spikes across Asia – UPI.com
Rapidly rising rates of heart disease across Southeast Asia, East Asia and Oceania are being driven by localized consequences of industrialization and rapid economic growth,…
Top Scientific Research Recognized at ACC Asia Conference – American College of Cardiology
Contact: Katie Glenn, kglenn@acc.org , The American College of Cardiology has recognized three outstanding abstract presentations as Abstract Award winners at the ACC Asia 2025…
Asia-Pacific Region Clinicians Named Fellows of American College of Cardiology – American College of Cardiology
Contact: Julie Boyland, Jboyland@acc.org, The American College of Cardiology (ACC) recognized more than 40 individuals from throughout the Asia-Pacific region who have earned the distinguished…
How much ultra-processed food is too much? The exact amount that raises your risk of heart disease and cancer
Each additional 3.5 ounces a day of ultra-processed food consumption was associated with a higher risk of a range of health issues.
Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.
Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.